Pandemic Accord Deliberations Stalled Over Patents and Intellectual Property Rights

GS Paper III

News Excerpt

Countries have finished the seventh round of deliberations on the pandemic accord. However, delegates failed to reach a consensus on intellectual property rights and relaxing patents. 

More details on news:

  • The deliberations aimed to strengthen international cooperation and address issues related to equitable vaccine distribution, particularly contentious topics like intellectual property rights (IPR) and patents.
  • Despite reaching an impasse, the deliberations concluded without a consensus on relaxing patents and IPR, hindering progress on ensuring fair access to medical products during emergencies.
  • The United States maintained its position in favor of protecting intellectual property rights, arguing that canceling them would not improve access for poorer countries during crises.
  • South Africa and India, supported by 100 countries, had proposed a waiver on intellectual property rights for COVID-19 vaccines and antivirals for at least three years, but the proposal was rejected by the World Trade Organization (WTO).
  • The international health regulation (IHR) was criticised for being ineffective during the COVID-19 pandemic. 
  • Developing countries emphasize the need for the equitable access to medical products.
  • Namibia's equity stance of representative at the Intergovernmental Negotiating Body (INB) highlighted tensions between richer and poorer nations during the deliberations.

Future aspects related to deliberations

  • Future deliberations may focus on resolving disagreements on intellectual property, ensuring equitable vaccine access, refining the pandemic treaty draft, and establishing effective governance for access and benefit-sharing systems.

Book A Free Counseling Session